Avance Clinical is the largest full-service Australian CRO specializing in delivering quality clinical trials, with globally accepted data, in Australia and New Zealand for international biotechs.
Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, has been providing CRO services in the region for the past 24 years.
The company’s clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.
Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.
With experience across more than 105 indications the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.
Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach.
As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of Avance Clinical’s trusted technology partners.
Visit http://www.avancecro.com for more information.
Recent Awards:
Excellence in Business Award 2021
Frost & Sullivan Asia-Pacific CRO Market Leadership Award 2020
Frost & Sullivan Asia-Pacific Customer Value Leadership Award 2021
Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, has been providing CRO services in the region for the past 24 years.
The company’s clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.
Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.
With experience across more than 105 indications the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.
Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach.
As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of Avance Clinical’s trusted technology partners.
Visit http://www.avancecro.com for more information.
Recent Awards:
Excellence in Business Award 2021
Frost & Sullivan Asia-Pacific CRO Market Leadership Award 2020
Frost & Sullivan Asia-Pacific Customer Value Leadership Award 2021
Location: Australia, South Australia, Adelaide
Employees: 51-200
Founded date: 2019
Investors 1
| Date | Name | Website |
| 28.03.2022 | The Rivers... | riversidec... |
Mentions in press and media 36
| Date | Title | Description |
| 28.06.2025 | Frost & Sullivan Recognizes Leading Organizations with Prestigious 2025 Best Practices Awards | Frost & Sullivan celebrates companies for their outstanding achievements at the Frost & Sullivan Best Practices Awards Gala SAN ANTONIO, June 28, 2025 /PRNewswire/ -- The best in business gathered in Los Angeles, California, at the ... |
| 14.05.2025 | Avance Clinical Honored with Frost & Sullivan's 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services | This award recognizes Avance Clinical's strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials. SAN ANTONIO, May 14, 2025 /PRNewswire/ -- Frost & Sullivan has named Avance C... |
| 16.03.2025 | Avance Clinical 與四個優質的台灣試驗單位簽訂諒解備忘錄，加強對美國生物科技公司的全球影響力 | 台北，台灣及阿德萊德，澳洲, March 17, 2025 (GLOBE NEWSWIRE) -- Avance Clinical 是一家全球頂尖的全方位服務受託研究機構 (CRO)，專門提供優質而靈活的臨床生物科技研究服務。該公司欣然宣佈本週與四個台灣主要的臨床試驗單位簽署了諒解備忘錄 (MOU)。 這些新的合作夥伴關係標誌著 Avance Clinical 在台灣的策略擴展，鞏固了該公司致力為美國生物科技公司在亞太區提供優質臨床研究解決方案的承諾。 Avance Clin... |
| 16.03.2025 | Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites | TAIPEI, Taiwan and ADELAIDE, Australia, March 17, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, is please... |
| 16.03.2025 | 助力美国生物科技公司全球扩张：Avance Clinical 与四家台湾一流试验机构签订 MOU | 台湾台北和澳大利亚阿德莱德, March 17, 2025 (GLOBE NEWSWIRE) -- 全球领先的全方位服务合同研究组织 (CRO) Avance Clinical 专注于高质量且灵活的临床生物科技研究服务。本周，Avance Clinical 欣然宣布与台湾重要临床试验机构签署了四项谅解备忘录 (MOU)。 这些新建立的合作伙伴关系标志着向台湾进行的战略扩张，再一次印证 Avance Clinical 为美国生物科技公司提供亚太地区高质量临床研究解决方案的决心。... |
| 13.09.2024 | Avance Clinical Joins the Australian Clinical Trials Roadshow, Sharing Cost and Time Benefits for Early-Phase US Biotechs | WAKE FOREST, N.C. and ADELAIDE, Australia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, the market-leading CRO for biotechs, announced today that Avance Clinical will represent the CRO sector at the Australian Clinical Trials Roadsho... |
| 04.09.2024 | Avance Clinical GlobalReady Site Partnership Network wächst schnell auf 2.000 Mitglieder an | WAKE FOREST, North Carolina und ADELAIDE, Australien, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, das preisgekrönte marktführende Auftragsforschungsinstitut für Biotechnologieunternehmen, gab heute bekannt, dass sich 2.000 klinische... |
| 04.09.2024 | Le réseau de partenariat de centres GlobalReady d’Avance Clinical s’étend à grande vitesse et réunit désormais 2 000 centres membres | WAKE FOREST, Caroline du Nord et ADÉLAÏDE, Australie, 04 sept. 2024 (GLOBE NEWSWIRE) -- Avance Clinical, l’ORC primé et leader sur le marché des biotechnologies, a annoncé ce jour que 2 000 centres cliniques en Amérique du Nord avaient rejo... |
| 04.09.2024 | Avance Clinical GlobalReady 地點合作夥伴網絡迅速擴展至 2,000 個地點成員 | 北卡羅來納州威克森林和澳洲阿德萊德, Sept. 04, 2024 (GLOBE NEWSWIRE) -- 屢獲殊榮的市場頂尖生物科技公司受託研究機構 (CRO) Avance Clinical 今天宣佈，在北美洲現已有 2,000 個臨床試驗地點加盟 Avance Clinical 的 GlobalReady 地點合作夥伴網絡 (GlobalReady Site Partnership Network)。 Avance Clinical 的行政總裁 Yvonne Lunge... |
| 04.09.2024 | Avance Clinical GlobalReady Site Partnership Network 迅速扩展至 2,000 个研究机构成员 | 北卡罗来纳州维克森林和澳大利亚阿德莱德, Sept. 04, 2024 (GLOBE NEWSWIRE) -- 今日,屡获殊荣的市场领先生物技术 CRO 公司 Avance Clinical 宣布，北美地区 2,000 家临床研究机构已加入 Avance Clinical GlobalReady Site Partnership Network。 Avance Clinical 首席执行官 Yvonne Lungershausen 表示，2,000 家高素质研究机构的加入，将... |
Show more